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There is huge commitment to public and patient involvement (PPI) in UK clinical
research. Despite there being wide agreement to practice PPI and national guidance
on the subject, there are few practical examples of how to implement PPI and few
published models to demonstrate how it can be achieved consistently and constructively
across a broad portfolio of studies. The Peninsula Research Bank demonstrates how good
PPI can be effectively integrated into experimental medicine research.
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When it was established in 2006, the National Institute for Health Research (NIHR)
made a bold statement that public involvement would be a core principle in the way it
worked. It signalled the beginning of a culture change in how UK health research is
conducted [1]. Over the past 8 years, there has been significant investment in public
and patient involvement (PPI) and a strong commitment to developing the patient in-
volvement agenda [2]. PPI has been reported in a number of specific research studies
and clinical trials [3], and there is excellent generic guidance available from INVOLVE
(http://www.invo.org.uk) on the principles of involving the public in research. However,
in a recent publication by NIHR on PPI, it was reported that individuals expressed diffi-
culty in understanding clearly what is required for public involvement and how to deliver
it [4]. There is no consensus on how to evaluate the effectiveness of PPI [4], and reports
of successful PPI rarely provide sufficient operational detail to be duplicated.
In this paper, we present a practical approach to bringing academic and patient com-
munities together to support a portfolio of clinical research studies and provide in-
sights from the viewpoint of both patient and researcher.
How the PRB Steering Committee has brought researchers and lay representatives
together to embed PPI in a research facility: Committee Chair Viewpoint
NIHR funds 19 clinical research facilities around the country to support and facilitate
experimental medicine research. NIHR Exeter Clinical Research Facility (CRF) has
been running a public involvement and engagement programme over the past 5 years.
This programme has evolved from a steering committee setup to advise on means to
increase participation in a research biobank (Exeter 10000) and to approve access to© 2015 Jenner et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jenner et al. Research Involvement and Engagement  (2015) 1:3 Page 2 of 6blood samples and participant data held in the Peninsula Research Bank (PRB). The
steering committee originally had two “nominal lay members”. However, it was soon
realised that handing lay members the key to the research bank’s resources was an
important step in involving them in research, and the group quickly evolved from
nominal lay membership to a PPI group.
What has developed is a co-dependent relationship with researchers and lay members
working together in an environment of mutual respect and collaboration. As well as seeking
lay approval for access to the research bank, researchers actively seek out our lay members
to discuss protocols, information sheets and research ideas and to improve dissemination.
No individual is representative of the public or a particular patient group. Anyone
can join the steering committee and there is no limit on overall numbers, but only two
to six steering committee lay members attend any single meeting on a rolling basis.
Our 27 currently active lay members put themselves forward either having already
participated in one of the CRF’s research projects or having attended one of the
CRF’s outreach events. All members receive the papers for each meeting 10 days
in advance by post or email and can send feedback on proposed projects by email,
postal letter or telephone, but there is no expectation for any of them to do this.
Members of the public from different walks of life participate on a flexible basis according
to their degree of availability, particular expertise and interest in a given project.
Papers can include lay descriptions of the proposed research, patient information
sheets, consent forms and any other document on which the researcher would like a
broader perspective. All comments received by email or telephone are collated and sent
to researchers so they can provide answers either before or during the meeting.
Minutes detailing all comments and researcher responses are collated and distributed
within 10 days of the meeting, and often, access to samples or volunteer data is subject
to conditions imposed by the steering committee. We do not choose individuals with
specific expertise or personal qualities, have no “Job Description” and do not provide
training or make training a requirement of participation. The agenda for each meeting
clearly specifies what involvement is required and which items are essential reading. In
addition, every meeting has an agenda item entitled “Lay member ideas”, which is an
open forum for lay members to steer our PPI activity. If lay members on our steering
committee wish to undergo training, we refer them to other organisations, such as
PenCLAHRC and the Research Network who provide courses and training days. Our
method of lay involvement promotes an interesting balance of representatives, from
those with no formal education keen to promote NHS research to their friends and
neighbours to retired professionals with the skills to question scientists about experi-
mental design and statistical validity.
Academic culture can often be very different from that of other spheres of work, and
bringing lay representatives into the research arena helps to raise awareness of issues
outside the academic culture box. This is particularly useful where researchers have
moved through first and second degrees into doctorates and post-doctoral research in
basic science. Lay members are more focussed on the practical aspects and outcomes
of research and how it can affect patients and carers. They raise practical questions
about study design, such as during a long study visit when can participants drink or
visit the toilet? Taking time to consider these practicalities ensures that study visits run
more smoothly. This means that participants feel better cared for and are more likely
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bers have had on the content and format of participant information sheets has been
significant. Suggestions such as “why don’t you include the consent statements in the
information sheet, so we know exactly what we are being asked to sign up to” not only
provide clarity for potential participants but speed up and improve the process of
obtaining informed consent. Lay members are interested in the translational outcomes
of research and help researchers to think through how their research can improve
healthcare. Close and regular dialogue can help researchers to consider these outcomes
and to prepare intelligible lay summaries of their research that will help generate realis-
tic timescales and avoid exaggerated forecasts of impact. This, in turn, may assist in
their applications for funding.
A key feature of our model is that all research projects running through our facility
are receiving involvement from a wide range of lay members. Individual lay members
may get involved at a deeper level in specific projects, but they have broad involvement
in everything that we do which means that on a monthly basis, there is always an
opportunity for researchers and lay members to share opinions and ideas. This differs
from many PPI models where individual projects are allocated one or two lay members
whose involvement may go through peaks and troughs.
Lay member viewpoint from Martin Jenner
There are ever increasing opportunities for public and patient involvement in health-
care research and service delivery. The demand currently outstrips supply, and there
are many local and national initiatives whose objectives include, or are solely focused
on, correcting this imbalance. One of the difficulties is the proliferation of ideas about
what constitutes PPI. As organisations accept the need for lay involvement, or have it
thrust upon them, they struggle to grasp the concept or resist the feeling of intrusion. I
believe that it is not possible to write a job description that avoids the idea of constrict-
ing the contribution of lay participants. Organisations need to adopt an open-minded
approach to how the general public through PPI can help them to achieve their objec-
tives; Non-executive Board Members are a valuable resource in most companies. The
special expertise that builds up in academic and administrative organisations can
inhibit innovative (out-of-the-box) thinking, and lay persons can often bring this to
benefit early-stage research design and programme delivery.
There are few limits other than those imposed by bureaucratic thinking. There is
nothing more damaging to realising the real potential than “tokenism”. I am pleased
that I am able to participate in the NIHR Exeter CRF’s PRB as a lay member. It has a
clear vision of how PPI fits into its operation and has evolved a practical, effective
implementation. It works and it is enjoyable.
The PPI team (they all have other roles) has generated an environment in which
everyone feels able to contribute with the certainty that their views and comments will
be valued. The communication channels between lay members and researchers are
open on all subjects (there is an absence of “no-go” areas) and are truly bi-directional.
By sympathetic chairing of meetings, fast and encouraging feedback and the genuine
enthusiasm of the research community in the CRF in Exeter, the PRB PPI programme
has overcome the initial pitfalls and has no shortage of lay participation. Above all, they are
constantly seeking to improve the experience for researchers and lay persons alike. It really
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research that is understandable, accessible and relevant to the wider community.
Researcher viewpoint from Mark Gilchrist
Early in my research career, I had the chastening experience of being unable to recruit
a single subject to one arm of a three-arm study. The other two arms were recruited
without difficulty. The consistent feedback from the patient group required for the
third arm was that on top of their regular visits to hospital; the study visits would be
an unacceptable burden. I soon realised that PPI groups are better placed to decide
whether what is being asked of them in research participation is reasonable and worth-
while. They will often raise issues that neither the originating investigators nor ethics
committees had considered. Subsequently, I have proactively involved potential research
participants and/or experienced service users at an early stage in my study design.
It has been educational to me to see the divergent opinions of the patients in PPI
groups and ethics committees. One area that has generated considerable debate is
patient information sheets. PPI groups have consistently asked for more concise infor-
mation sheets, whereas some ethics committees prefer longer more detailed informa-
tion sheets. From discussions with PPI groups, it is evident that a brief, clear
information sheet is more likely to be read and understood than a more exhaustive
document. It is helpful in ethics meetings to be able to answer questions from the
committee with evidence from a PPI group.
Research participants will only take part in studies which they deem to be of value.
PPI groups give the researcher the chance to explain their work and its importance to
an audience of individuals who are experienced in particular medical conditions. There
is scope for learning what will concern potential participants and what may enhance or
hinder recruitment and retention.
Conclusions
The model for PPI adopted by the PRB at NIHR Exeter CRF provides a consistent and
constructive framework for lay members and researchers to work together to improve
experimental medicine research. This model can be applied to any organisation with a
portfolio of several research studies for which broad lay involvement is needed. It is
also an ideal spring board to involve lay members more deeply in specific projects.
Key to the operational running of this model is central management playing a facilita-
tive role between researchers and lay representatives. The NIHR Exeter CRF provides
less than 1 day a week of staff time to support to manage this relationship and to
ensure that the 30–50 studies per year have public and patient involvement. Where an
organisation has a full-time member of staff involved in PPI, they should be able to use
this model to embed broad PPI in a large portfolio of research and can use this as an
opportunity to develop deeper involvement in studies where the public can play a vital
role as co-applicants.
Our model is particularly effective to use where lay members have donated samples
to a tissue bank or joined a research register, as they are specifically interested in ensur-
ing samples/data are used for the very best research.
There has been debate surrounding the relative merits of broad or dynamic consent
for tissue banks [5]. Broad consent asks participants to consent to their samples being
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Dynamic consent involves taking the samples and then going back to individual donors
and asking them to re-consent each time their samples are used.
The PRB obtains broad consent from all donors, but all projects using samples or
data within the bank are scrutinised by the lay steering committee (PPI group), who are
themselves donors. This approach results in a proportion of the participants being
engaged in dynamic consent. Ensuring dynamic consent for all donors in a tissue bank
is an administratively difficult and costly exercise, as donors change their contact de-
tails. Confirming that all participants understand what is involved in every research
project would also be operationally difficult in a large biobank, as truly informed con-
sent would involve them being able to ask questions of the researcher, which is not
feasible when a researcher wants to use 1000 s of DNA samples. In addition, many do-
nors prefer not to be bombarded with specific requests and paperwork. As membership
of the PRB is open to anyone, including any person who has donated samples to the
bank, it allows individuals with an interest in what is being done with their samples to
have a voice in approving access on behalf of the whole cohort. This model of broad
consent plus “dynamic consent by proxy” improves the ethical standard of the biobank
but also provides a practical, consistent and constructive framework for involving the
public in research, as regular meetings are needed between lay members and scientists
to approve access to samples. The PRB started as a committee to approve access to
samples, but developed into a PPI group, as lay members started asking to be involved
more deeply in the studies that they were approving and researchers realised that early
dialogue improved their study design and participant-facing materials.
For more information on the operational details of the PRB Steering Committee, such as
copies of minutes and example information sheets, see www.exeter.crf.nihr.ac.uk/PRB.
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